Seldon Capital’s Boston Scientific BSX Stock Holding History

Seldon Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,938	Closed	-$208K	–	71
2025 Q2	$208K	Buy	+1,938	New	+$196K	0.09%	63
2023 Q1	–	Sell	-1,938	Closed	-$89.7K	–	79
2022 Q4	$89.7K	Hold	1,938	–	–	0.08%	89
2022 Q3	$75K	Hold	1,938	–	–	0.05%	98
2022 Q2	$72K	Hold	1,938	–	–	0.04%	113
2022 Q1	$86K	Hold	1,938	–	–	0.05%	114
2021 Q4	$82K	Buy	+1,938	New	+$81.4K	0.05%	124

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Seldon Capital's BSX Position: Q3 2025 in Review

Seldon Capital sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 1,938 shares — an estimated $208K sold.

Seldon Capital first reported a position in BSX in Q4 2021 and held it in 6 quarters. The position peaked at $208K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Seldon Capital reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Seldon Capital sold 1,938 Boston Scientific shares in Q3 2025, an estimated $208K.
Seldon Capital first reported a position in Boston Scientific in Q4 2021 and held it in 6 quarters.
Seldon Capital's Boston Scientific position peaked at $208K in Q2 2025.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Seldon Capital's 13F filing for Q3 2025, filed 14 Nov 2025.